L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.88 NOK 0.88% Market Closed
Market Cap: 341.3m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Lytix Biopharma AS
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lytix Biopharma AS
Net Income (Common) Peer Comparison

Comparables:
HBC
B
BGBIO
AZT
N
NYKD
T
TRMED

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
L
Lytix Biopharma AS
OSE:LYTIX
Net Income (Common)
-kr87.9m
CAGR 3-Years
-28%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Net Income (Common)
-kr121.2m
CAGR 3-Years
-2%
CAGR 5-Years
-8%
CAGR 10-Years
-12%
B
Bergenbio ASA
OSE:BGBIO
Net Income (Common)
-kr155.4m
CAGR 3-Years
21%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Net Income (Common)
kr14.6m
CAGR 3-Years
-40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Net Income (Common)
-$37.9m
CAGR 3-Years
N/A
CAGR 5-Years
-50%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Net Income (Common)
-kr39.6m
CAGR 3-Years
54%
CAGR 5-Years
36%
CAGR 10-Years
0%

See Also

What is Lytix Biopharma AS's Net Income (Common)?
Net Income (Common)
-87.9m NOK

Based on the financial report for Dec 31, 2023, Lytix Biopharma AS's Net Income (Common) amounts to -87.9m NOK.

What is Lytix Biopharma AS's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-7%

Over the last year, the Net Income (Common) growth was -57%. The average annual Net Income (Common) growth rates for Lytix Biopharma AS have been -28% over the past three years , -7% over the past five years .

Back to Top